ATA Action Responds to FDA on Generative AI Medical Devices: Two-Axis Risk, PCCPs, and Manufacturer Accountability - HIT Consultant
ATA Action Responds to FDA on Generative AI Medical Devices: Two-Axis Risk, PCCPs, and Manufacturer Accountability HIT Consultant